Alcoholic Hepatitis clinical trials at University of California Health

1 research study open to eligible people

Study of an Investigational Drug for Alcoholic Hepatitis
“Volunteer for research and contribute to discoveries that may improve health care for you, your family, and your community!”
open to eligible people ages 18 years and up
This is a randomized, double-blind, placebo-controlled, phase 2b clinical Trial evaluating Safety and Efficacy of DUR-928 (an experimental medication) in Patients with Alcoholic Hepatitis (AH).
at UC Davis UCSF

Last updated: November 2022